1.
Ann Rheum Dis
; 82(6): e131, 2023 06.
Article
in English
| MEDLINE
| ID: mdl-33692020
Subject(s)
COVID-19 , Rheumatic Diseases , Humans , SARS-CoV-2 , Antibody Formation , Rheumatic Diseases/complications , Rituximab , Vaccination
2.
Ann Rheum Dis
; 81(2): 289-291, 2022 02.
Article
in English
| MEDLINE
| ID: mdl-34489304
Subject(s)
Autoimmune Diseases/virology , COVID-19/mortality , Rheumatic Diseases/virology , SARS-CoV-2 , Adult , Antirheumatic Agents/therapeutic use , Autoimmune Diseases/drug therapy , COVID-19/therapy , COVID-19/virology , COVID-19 Vaccines , Female , Hospitalization/statistics & numerical data , Humans , Male , Middle Aged , Rheumatic Diseases/drug therapy
3.
Ann Rheum Dis
; 81(8): e135, 2022 08.
Article
in English
| MEDLINE
| ID: mdl-32660976
4.
Ann Rheum Dis
; 80(5): e64, 2021 05.
Article
in English
| MEDLINE
| ID: mdl-32546600
Subject(s)
COVID-19 , Rheumatic Diseases , China , Humans , Rheumatic Diseases/drug therapy , SARS-CoV-2 , Tumor Necrosis Factor Inhibitors
5.
Ann Rheum Dis
; 79(4): e40, 2020 04.
Article
in English
| MEDLINE
| ID: mdl-30700422